184 related articles for article (PubMed ID: 30250588)
1. Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
Wang S; Chen X
Oncol Lett; 2018 Oct; 16(4):5200-5208. PubMed ID: 30250588
[TBL] [Abstract][Full Text] [Related]
2. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
[TBL] [Abstract][Full Text] [Related]
3. Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis.
Dai F; Chen G; Wang Y; Zhang L; Long Y; Yuan M; Yang D; Liu S; Cheng Y; Zhang L
Onco Targets Ther; 2019; 12():4517-4532. PubMed ID: 31354287
[No Abstract] [Full Text] [Related]
4. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.
Yang B; Dai JX; Pan YB; Ma YB; Chu SH
Oncol Lett; 2019 Dec; 18(6):6079-6089. PubMed ID: 31788082
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers of intrahepatic cholangiocarcinoma via integrated analysis of mRNA and miRNA microarray data.
Chen Y; Liu D; Liu P; Chen Y; Yu H; Zhang Q
Mol Med Rep; 2017 Mar; 15(3):1051-1056. PubMed ID: 28098904
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
[TBL] [Abstract][Full Text] [Related]
7. Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
Liu Y; Hua T; Chi S; Wang H
Oncol Lett; 2019 Jan; 17(1):897-906. PubMed ID: 30655845
[TBL] [Abstract][Full Text] [Related]
8. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
9. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
10. An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
Li D; Hao X; Song Y
Onco Targets Ther; 2018; 11():3075-3085. PubMed ID: 29872319
[TBL] [Abstract][Full Text] [Related]
11. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Wang W; Wang S; Pan L
Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
[TBL] [Abstract][Full Text] [Related]
12. Identification of key miRNA-gene pairs in chronic lymphocytic leukemia through integrated analysis of mRNA and miRNA microarray.
Li J; Qin Y; Zhang H
Oncol Lett; 2018 Jan; 15(1):361-367. PubMed ID: 29285196
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
14. Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.
Liu B; Yang H; Taher L; Denz A; Grützmann R; Pilarsky C; Weber GF
Transl Oncol; 2018 Jun; 11(3):700-714. PubMed ID: 29631214
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential therapeutic targets for colorectal cancer by bioinformatics analysis.
Yan M; Song M; Bai R; Cheng S; Yan W
Oncol Lett; 2016 Dec; 12(6):5092-5098. PubMed ID: 28105216
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential therapeutic target genes in mouse mesangial cells associated with diabetic nephropathy using bioinformatics analysis.
Mou X; Zhou DY; Liu YH; Liu K; Zhou D
Exp Ther Med; 2019 Jun; 17(6):4617-4627. PubMed ID: 31105790
[TBL] [Abstract][Full Text] [Related]
18. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
[TBL] [Abstract][Full Text] [Related]
19. Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis.
Zhang L; Lu D; Liu M; Zhang M; Peng Q
Mol Med Rep; 2019 Sep; 20(3):2316-2324. PubMed ID: 31322209
[TBL] [Abstract][Full Text] [Related]
20. Identification of key genes and microRNAs involved in kidney Wilms tumor by integrated bioinformatics analysis.
Zhang L; Gao X; Zhou X; Qin Z; Wang Y; Li R; Tang M; Wang W; Zhang W
Exp Ther Med; 2019 Oct; 18(4):2554-2564. PubMed ID: 31555364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
